Palosuran sulfate

N/A

Report date: 2022/05/17 17:46:05
NME

Base Information

Drug NamePalosuran sulfate
Drug Alias Namepalosuranum硫酸帕洛舒仑palosuran帕洛舒仑硫酸盐ACT-058362
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUrotensin II receptor antagonists
TargetsUrotensin II receptor
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesActelion Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksN/A